mestermű Eskü örökség federica arpicco ón visszaesik Alaposan
Molecules | Free Full-Text | Hyaluronic Acid–Decorated Liposomes as Innovative Targeted Delivery System for Lung Fibrotic Cells
Federica Arpicco is coming soon
Silvia ARPICCO | Professor (Full) | Professor | Università degli Studi di Torino, Turin | UNITO | Dipartimento di Scienza e Tecnologia del Farmaco | Research profile
Design and Synthesis of New Withaferin A Inspired Hedgehog Pathway Inhibitors - Bonandi - 2021 - Chemistry – A European Journal - Wiley Online Library
Federica FOGLIETTA | PhD in Pharmaceutical and Biomecular Sciences | PhD in Pharmaceutical and Biomolecular Sciences | Università degli Studi di Torino, Turin | UNITO | Dipartimento di Scienza e Tecnologia del Farmaco | Research profile
Multifunctional Neomycin-Triazine-Based Cationic Lipids for Gene Delivery with Antibacterial Properties - ScienceDirect
Paclitaxel Derivatives for Targeted Therapy of Cancer: Toward the Development of Smart Taxanes | Journal of Medicinal Chemistry
Liposomes Loaded with Everolimus and Coated with Hyaluronic Acid: A Promising Approach for Lung Fibrosis
Targeted Delivery of Protein Drugs by Nanocarriers – topic of research paper in Nano-technology. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Anticancer Therapeutics: Targeting Macromolecules and Nanocarriers to Hyaluronan or CD44, a Hyaluronan Receptor | Molecular Pharmaceutics
Bovine seminal ribonuclease triggers Beclin1-mediated autophagic cell death in pancreatic cancer cells - ScienceDirect
Hyaluronic Acid-Decorated Chitosan Nanoparticles for CD44-Targeted Delivery of Everolimus
Biomedical Applications of Reactive Oxygen Species Generation by Metal Nanoparticles
Molecules | Special Issue : Hyaluronic Acid and its Derivatives for Biomedical Applications
dott.ssa Federica Arpicco – medical center in Torino, reviews, prices – Nicelocal
Liposomal formulation for the treatment of fibrogenic lung disorders | Knowledgeshare
ISCaM2022A
Targeted nanotherapy with everolimus reduces inflammation and fibrosis in scleroderma‐related interstitial lung disease developed by PSGL‐1 deficient mice - González‐Sánchez - 2022 - British Journal of Pharmacology - Wiley Online Library